|
continued further
and so this observed increase may have been due to clinical fluctuations and not related to the treatment, they said. Exemestane was associated with an increase in high-density lipoprotein cholesterol and also increases in the ratio of low- to high-density lipoprotein cholesterol and the ratio of apolipoprotein apoB to apoA-1, all of which suggest a possible atherogenic effect, the group commented.
SABC Symposium: Abstracts 2092, 3131, 5068, and 507. Presented December 15 and 16, 2006.
|